Saturday, January 28, 2023
HomeTagsBiotech

Biotech

Biotech Acquisition Company and Blade Therapeutics Mutually Agree to Terminate Business Combination Agreement

Biotech Acquisition Company, a publicly traded special purpose acquisition company affiliated with SPRIM Global Investments, and Blade Therapeutics, Inc. ("Blade"), a biopharmaceutical company based...

Biotech Acquisition Company and Blade Therapeutics Announce Postponement of Extraordinary Meeting of Shareholders

Biotech Acquisition Company, a publicly traded special purpose acquisition company affiliated with SPRIM Global Investments, and Blade Therapeutics, Inc. ("Blade"), a biopharmaceutical company based...

Eat Well Group Inc. Granted MCTO

Eat Well Investment Group Inc. (“Eat Well” or the “Company”) announces that its principal regulator, the British Columbia Securities Commission, has accepted the Company’s...

Cenobamate (ONTOZRY®), for the Treatment of Drug-Resistant Focal-Onset Seizures in Adults, Is Now Available in the Netherlands

Angelini Pharma, international pharmaceutical company part of the privately held Italian Angelini Group announced  that ONTOZRY® (cenobamate) is now available in the Netherlands for...

Reata Pharmaceuticals Completes Rolling Submission of New Drug Application for Omaveloxolone for the Treatment of Patients with Friedreich’s Ataxia

Reata Pharmaceuticals, Inc. a clinical-stage biopharmaceutical company, announced the completion of the rolling submission of a New Drug Application (“NDA”) to the U.S. Food...
0FansLike
3,682FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics